Carl Zeiss Meditec AG

1AFX

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,784

Stocks News & Analysis

stocks

Lower production and higher prices for ASX hydrocarbon play

Improving pricing offsets severe weather impact on sales volumes.
stocks

Alphabet returns on AI investments accelerating

AI propels business across aegments, cloud is grightest; Increasing our fair value.
stocks

We lift our fair value estimate for this ASX energy play

Strong oil and LNG prices are a major win, though we don’t think they will stay high in the long term.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,887.6017.100.19%
CAC 407,970.09102.04-1.26%
DAX 4023,896.1458.42-0.24%
Dow JONES (US)48,861.81280.12-0.57%
FTSE 10010,266.4353.320.52%
HKSE25,776.53335.31-1.28%
NASDAQ24,673.249.440.04%
Nikkei 22559,284.92632.54-1.06%
NZX 50 Index12,903.31133.011.04%
S&P 5007,135.952.85-0.04%
S&P/ASX 2008,665.8025.600.30%
SSE Composite Index4,112.164.650.11%

Market Movers